OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 17:27:20 04/06/2024 BST | ||
| 2.73 EUR | -1.09% |
|
| Current month | +2.60% | ||
| 1 month | +14.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 04/06/24 | 2.73 | -1.09% |
| 03/06/24 | 2.76 | +2.60% |
| 31/05/24 | 2.69 | +7.17% |
| 30/05/24 | 2.51 | +0.40% |
| 29/05/24 | 2.5 | -3.47% |
Real-time BOERSE MUENCHEN
Last update June 04, 2024 at 05:27 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG4MZK |
| ISIN | DE000GG4MZK8 |
| Date issued | 01/03/2024 |
| Strike | 112.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.4 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.12 € |
|---|---|
| Lowest since issue | 1.44 € |
| Spread | 0.05 € |
| Spread % | 1.77% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.1
USD
Average target price
147
USD
Spread / Average Target
+4.17%
- Stock Market
- Certificates
- Certificat
